MyD88-Dependent Signaling Contributes to Host Defense against Ehrlichial Infection

DSpace/Manakin Repository

MyD88-Dependent Signaling Contributes to Host Defense against Ehrlichial Infection

Citable link to this page

. . . . . .

Title: MyD88-Dependent Signaling Contributes to Host Defense against Ehrlichial Infection
Author: Koh, Young-Sang; Koo, Jung-Eun; Biswas, Amlan; Kobayashi, Koichi S

Note: Order does not necessarily reflect citation order of authors.

Citation: Koh, Young-Sang, Jung-Eun Koo, Amlan Biswas, and Koichi S. Kobayashi. 2010. MyD88-Dependent signaling contributes to host defense against ehrlichial infection. PLoS ONE 5(7): e11758.
Full Text & Related Files:
Abstract: The ehrlichiae are small Gram-negative obligate intracellular bacteria in the family Anaplasmataceae. Ehrlichial infection in an accidental host may result in fatal diseases such as human monocytotropic ehrlichiosis, an emerging, tick-borne disease. Although the role of adaptive immune responses in the protection against ehrlichiosis has been well studied, the mechanism by which the innate immune system is activated is not fully understood. Using Ehrlichia muris as a model organism, we show here that MyD88-dependent signaling pathways play a pivotal role in the host defense against ehrlichial infection. Upon E. muris infection, MyD88-deficient mice had significantly impaired clearance of E. muris, as well as decreased inflammation, characterized by reduced splenomegaly and recruitment of macrophages and neutrophils. Furthermore, MyD88-deficient mice produced markedly lower levels of IL-12, which correlated well with an impaired Th1 immune response. In vitro, dendritic cells, but not macrophages, efficiently produced IL-12 upon E. muris infection through a MyD88-dependent mechanism. Therefore, MyD88-dependent signaling is required for controlling ehrlichial infection by playing an essential role in the immediate activation of the innate immune system and inflammatory cytokine production, as well as in the activation of the adaptive immune system at a later stage by providing for optimal Th1 immune responses.
Published Version: doi:10.1371/journal.pone.0011758
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909256/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:4768917

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters